Results 11 to 20 of about 42,441 (299)

Ventricular Arrhythmias After Left Ventricular Assist Device [PDF]

Circulation: Arrhythmia and Electrophysiology, 2013
Despite advances in medical therapy, heart failure remains one of the major causes of hospitalizations and deaths in the United States. Approximately 5.7 million patients have heart failure, and it is the direct cause of death for 57 000 individuals annually.1 Although the combination of optimal medical therapy, implantable cardioverter-defibrillators (
Shashima, Nakahara, Christopher, Chien, Jill, Gelow, Khidir, Dalouk, Charles A, Henrikson, James, Mudd, Eric C, Stecker   +6 more
openaire   +2 more sources

First Case Report of Electromagnetic Interference Between Percutaneous Ventricular Assist Device and Implantable Cardioverter-Defibrillator

JACC: Case Reports, 2023
Electromagnetic interference (EMI) between implantable left ventricular assist devices and cardiac implantable electronic devices has been observed. We demonstrated the first case of EMI between a percutaneous ventricular assist device and an implantable
Kosuke Takahari, MD, Takafumi Oka, MD, PhD, Takayuki Sekihara, MD, Kentaro Ozu, MD, Yasuhiro Akazawa, MD, PhD, Daisuke Nakamura, MD, Isamu Mizote, MD, PhD, Tomohito Ohtani, MD, PhD, Shungo Hikoso, MD, PhD, Yasushi Sakata, MD, PhD   +9 more
doaj   +1 more source

Interventional Microbubble Enhanced Sonothrombolysis on Left Ventricular Assist Devices

Advanced Science, 2022
The left ventricular assist device (LVAD) is often used in the treatment of heart failure. However, 4% to 9% implanted LVAD will have thrombosis problem in one year, which is fatal to the patient's life.
Xiaobing Zheng, Yunfan Pan, Yuan Zhang, Kuilin Meng, Jianye Zhou, Xin Wang, Yongchun Cui, Jiang Li, Yongjian Li, Haosheng Chen   +9 more
doaj   +1 more source

Long-Term renal function after implantation of continuous-flow left ventricular assist devices: A single center study

International Journal of Cardiology: Heart & Vasculature, 2021
Background: Implantable continuous-flow left ventricular assist device (LVAD) improve renal function in advanced heart failure. However, the long-term effects of LVAD on renal function have not been investigated thoroughly.
Chie Bujo, Eisuke Amiya, Masaru Hatano, Junichi Ishida, Masaki Tsuji, Nobutaka Kakuda, Koichi Narita, Akihito Saito, Hiroki Yagi, Masahiko Ando, Shogo Shimada, Mitsutoshi Kimura, Osamu Kinoshita, Minoru Ono, Issei Komuro   +14 more
doaj   +1 more source

Left Ventricular Assist Devices [PDF]

Circulation, 2018
Ventricular assist device has rapidly emerged as a durable and safe therapy for end-stage heart failure patients with >22 000 implantations to date. Though originally conceived for bridge-to-transplant indication, significant advancements in medical management as well as technology with arrivals of newer generation devices have improved patient ...
Jason J. Han, Michael A. Acker, Pavan Atluri   +2 more
openaire   +1 more source

Factors influencing transfusion-associated HLA sensitization in patients bridged to heart transplantation using ventricular assist device. [PDF]

, 2020
BackgroundBridging heart failure patients with mechanical ventricular assist devices (VAD) enables access to transplantation. However, VAD is associated with increased risk for anti-HLA antibodies associated with rejection of subsequent allografts ...
Adler, Eric, Elkind, Jae, Morris, Gerald P, Ostberg-Braun, Oscar, Silva Enciso, Jorge, Sobczyk, Juliana   +5 more
core   +1 more source

Choosing Between Left Ventricular Assist Devices and Biventricular Assist Devices

Cardiac Failure Review, 2019
Right ventricular failure following left ventricular assist devices implantation is a serious complication associated with high mortality. In patients with or at high risk of developing right ventricular failure, biventricular support is recommended ...
Sajad Shehab, Christopher S Hayward
doaj   +1 more source

Pressure, Flow Rate and Operating Speed Characteristics of a Continuous Flow Left Ventricular Assist Device During Varying Speed Support

IEEE Access, 2020
Hydraulic performance of Continuous Flow Left Ventricular Assist Devices depends on their pressure head and flow rate relations. Hydraulic characteristics of these devices are expressed by pressure head and flow rate loops in a pulsatile environment as ...
Selim Bozkurt
doaj   +1 more source

Transcatheter valvular therapies in patients with left ventricular assist devices

Frontiers in Cardiovascular Medicine, 2023
Aortic, mitral and tricuspid valve regurgitation are commonly encountered in patients with continuous-flow left ventricular assist devices (CF-LVADs). These valvular heart conditions either develop prior to CF-LVAD implantation or are induced by the pump
Olina Dagher, Olina Dagher, Olina Dagher, Marcel Santaló-Corcoy, Marcel Santaló-Corcoy, Nils Perrin, Nils Perrin, Nils Perrin, Jean-François Dorval, Jean-François Dorval, Neal Duggal, Thomas Modine, Anique Ducharme, Anique Ducharme, Yoan Lamarche, Pierre-Emmanuel Noly, Anita Asgar, Anita Asgar, Walid Ben Ali, Walid Ben Ali   +19 more
doaj   +1 more source

Initial experience with the left ventricular assist device TransCoreTM [PDF]

, 2010
Cardiogenic shock is a condition associated to high mortality rates. For decades, the treatment consisted of vasoactive drugs and intra-aortic balloon pump.
Alves, Claudia Maria Rodrigues, Lima, Valter Correia De, Minohara, Stéfano Franco, Souza, Cristiano Freitas De   +3 more
core   +1 more source